3.5. GM-080 Alleviates PAR in Children
Finally, we conducted a double-blind, randomized, placebo-controlled trial to investigate the beneficial effects of GM-080 in children with PAR. The study design was summarized in We next examined the effects of GM-080 on patients’ quality of life by using TNSSs. TNSSs are a convenient tool for symptom description and the assessment of functional problems (physical, emotional, social, and occupational) associated with AR. We noted a nonsignificant decrease in TNSSs over time in groups A, B, and C (Additional well-designed clinical trials are warranted to identify the most effective dosage of GM-080.